This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Sep 8;8(9):469.

doi: 10.1038/nrurol.2011.121.

Prostate cancer: intermediate-risk patients on radiotherapy benefit from addition of short-term ADT

PMID: 21901016
DOI: 10.1038/nrurol.2011.121

Comment

Prostate cancer: intermediate-risk patients on radiotherapy benefit from addition of short-term ADT

Sarah Payton. Nat Rev Urol. 2011.

. 2011 Sep 8;8(9):469.

doi: 10.1038/nrurol.2011.121.

Author

PMID: 21901016
DOI: 10.1038/nrurol.2011.121

No abstract available

PubMed Disclaimer

Comment on

Radiotherapy and short-term androgen deprivation for localized prostate cancer.
Jones CU, Hunt D, McGowan DG, Amin MB, Chetner MP, Bruner DW, Leibenhaut MH, Husain SM, Rotman M, Souhami L, Sandler HM, Shipley WU. Jones CU, et al. N Engl J Med. 2011 Jul 14;365(2):107-18. doi: 10.1056/NEJMoa1012348. N Engl J Med. 2011. PMID: 21751904 Clinical Trial.

References

1. N Engl J Med. 2011 Jul 14;365(2):107-18 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.